About NeuroVision
NeuroVision is a company based in Sacramento (United States) founded in 2010 by Steven Verdooner. NeuroVision has raised $31.6 million across 8 funding rounds from investors including Johnson & Johnson Innovative Medicine, HHS and Alzheimer's Drug Discovery. The company has 13 employees. NeuroVision offers products and services including BrainHealth.net and Afinaâ„¢ Retinal Imaging. NeuroVision operates in a competitive market with competitors including Tobii Dynavox, Neurotrack, Artiria, NovaSight and PD Neurotechnology, among others.
- Headquarter Sacramento, United States
- Employees 13
- Founders Steven Verdooner
- SectorsHealthcareTechnology
- Website neurovision.com
- Social LinkedIn
- Legal Name Neurovision Imaging, Inc.
- Total Equity Funding$31.6M (USD)
in 8 rounds
- Investors
- Employee Count13
Products & Services of NeuroVision
NeuroVision offers a comprehensive portfolio of products and services, including BrainHealth.net and Afina™ Retinal Imaging.
Platform for screening and managing cognitive health services
AI tool for detecting amyloid in retina related to Alzheimer's
Funding Insights of NeuroVision
NeuroVision has successfully raised a total of $31.6M across 8 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $31.6M
- Total Rounds 8
- First Round $150,874
(Jul 2013)
- Investors Count 8
All 8 funding rounds of NeuroVision with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2021 | – | Series C | – | – | |
| Feb 2021 | – | Series C | – | – | |
| May 2018 | $11.2M | Series C | – | – | – |
| May 2018 | $11.2M | Series C | – | Wildcat Capital Management | |
| Jun 2016 | $5M | Series B | – | – | |
| Feb 2016 | – | Series A | – | – | |
| Jun 2014 | $4.2M | Seed | – | – | – |
| Jul 2013 | $150,874 | Grant | – | – |
8 investors in total: 8 institutional.
Investors in NeuroVision
NeuroVision has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include Johnson & Johnson Innovative Medicine, HHS and Alzheimer's Drug Discovery.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital funds are managed to support unlisted companies' growth. | – | sbinvestment.co.jp | Minato City, Japan | |
Drugs for Alzheimer's prevention, treatment, and cure are discovered. | 1998 | alzdiscovery.org | New York, United States | |
VSP Vision is engaged in providing comprehensive eye care solutions. | – | vspglobal.com | Rancho Cordova, United States | |
- | – | jnjinnovation.com | - | |
Provides wealth management, investments, trust services, and family office support. | 1989 | whittiertrust.com | South Pasadena, United States | |
Provides equity capital and strategic advice to growth-oriented companies across sectors. | 2011 | wildcatcap.com | New York, United States | |
Diversified drugs are manufactured for various therapeutic areas. | 1953 | janssen.com | Raritan, United States | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov | - |
Investor details for NeuroVision
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of NeuroVision
4 people are tracked at NeuroVision (3 in leadership, 1 in team); the tracked headcount is 13.
| Name | Role | Group |
|---|---|---|
Steven Verdooner | Co-Founder & CEO | Leadership |
Traci Lee Chu | Consulting VP Marketing | Leadership |
Christina Teng | Head Of Customer Experience | Leadership |
Leyla Anderson, MD, PhD, D(ABMLI) | Svp, Scientific Affairs & Alliances | Team |
Complete people profiles for NeuroVision
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of NeuroVision
3 dated milestones of NeuroVision across 11 years, from founding to its latest funding, stage changes and deals.
- Founded NeuroVision is founded.
- Funding First funding round of $151K.
- Funding Latest funding round, Series C,.
Competitors of NeuroVision
NeuroVision operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tobii Dynavox, Neurotrack, Artiria, NovaSight and PD Neurotechnology, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| tobiidynavox.com | 1983 | Danderyd, Sweden | – | – | Assistive communication solutions via eye-tracking are provided for differently-abled individuals. | |
| neurotrack.com | 2012 | Redwood, United States | $57.81M | – | Neurological disorders are diagnosed using eye-tracking assessment tools. | |
| artiria-medical.com | 2019 | Lausanne, Switzerland | $9.19M | – | Micro-navigation systems for stroke surgery are developed. | |
| nova-sight.com | 2016 | Lod, Israel | $8M | – | Eye-tracking solutions for vision assessment and treatment are provided. | |
| pdneurotechnology.com | 2015 | London, United Kingdom | $93.34M | 32 | A wearable device is developed to monitor Parkinson's movement disorders. | |
| iota.bio | 2017 | Berkeley, United States | $15M | – | Developer of neurodiagnostic techniques | |
| clighttechnologies.com | 2014 | Berkeley, United States | $2.5M | – | Eye-tracking devices are developed for neurodegenerative disease monitoring. | |
| oculogica.com | 2013 | New York, United States | $21.98M | – | Eye-tracking technology is utilized to detect traumatic brain injuries. | |
| winterlightlabs.com | 2015 | Toronto, Canada | $5.73M | – | Cognitive impairment signs are detected through speech sample analysis. |
Detailed competitors of NeuroVision
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of NeuroVision
The website of NeuroVision (neurovision.com) receives about 1.7K visits a month.
- Monthly visits1.7K
▼ 6.1% vs previous month
Latest news on Neurovision
Complete news archive for NeuroVision
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to NeuroVision
10 companies that operate in the same segment as NeuroVision (Clinical IT & Data Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of fitness memberships encompassing group classes, gyms, and at-home workouts | 2016 | Bengaluru, Karnataka, India | USD 713.57 M | – | – | |
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | – | – | |
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 233 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | – | – | |
Tech-enabled mental health solutions for employers are provided. | 2016 | New York, New York, United States | USD 508.73 M | – | – | |
App-based health insurance is offered to individuals and businesses. | 2016 | Paris, France | USD 863.12 M | – | – | |
Virtual care programs for managing chronic diseases are provided. | 2011 | San Francisco, California, United States | USD 450.12 M | USD 260.21 M | – | |
AI-driven EMR and practice management software is delivered for clinics. | 2010 | Boca Raton, Florida, United States | USD 329.17 M | – | – | |
Cloud-based administrative tools for healthcare providers are offered. | 1997 | Watertown, United States | USD 40 M | – | – | |
Membership-based primary care platform is offered for employees and consumers. | 2007 | San Francisco, California, United States | USD 402.56 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about NeuroVision
NeuroVision was founded in 2010 and raised its 1st funding round 3 years after it was founded.
NeuroVision is headquartered in Sacramento, United States. It is registered at Sacramento, California, United States.
Steven Verdooner is the current CEO of NeuroVision. They have also founded this company.
NeuroVision is a funded company, having raised a total of $31.6M across 8 funding rounds to date. The company's 1st funding round was a Grant of $150.87K, raised on Jul 2013.
NeuroVision has 13 employees.
NeuroVision was founded in 2010 in Sacramento, United States, within the neuroscience sector. Diagnostic tests and biomarkers for early detection of amyloid pathology in Alzheimers disease are developed by the company. Retinal imaging technology called Afina is utilized for visualization and measurement of retinal health. Datasets are aggregated, analyzed through biostatistics, and processed with machine learning algorithms to predict neurodegenerative diseases.
NeuroVision's top competitors include NovaSight, iota Biosciences and Tobii Dynavox.
NeuroVision offers BrainHealth.net and Afinaâ„¢ Retinal Imaging.
NeuroVision has 8 investors. Key investors include Johnson & Johnson Innovative Medicine, HHS, Alzheimer's Drug Discovery, VSP Vision, and Johnson & Johnson Innovation.
NeuroVision operates through Neurovision Imaging, Inc..